Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 510 is a 683-amino acid transcription factor localized on chromosome 9 in humans. It contains C2H2-type zinc-finger domains, structural motifs commonly involved in DNA binding and gene regulatory processes. ZNF510 is expressed in several cancer cell types and has been suggested as a biomarker for early cancer diagnosis. Its main molecular function is transcriptional regulation, consistent with its classification as a zinc-finger protein and nucleic acid-binding factor. No approved drugs are currently known to directly target ZNF510, and no specific safety concerns have been reported for targeting this protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 510 (ZNF510).